You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2024

List of Excipients in API sparsentan

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing sparsentan

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Travere Therapeutics Inc	FILSPARI	sparsentan	68974-200	ANHYDROUS LACTOSE	2031-09-05
Travere Therapeutics Inc	FILSPARI	sparsentan	68974-200	CELLULOSE, MICROCRYSTALLINE	2031-09-05
Travere Therapeutics Inc	FILSPARI	sparsentan	68974-200	MAGNESIUM STEARATE	2031-09-05
Travere Therapeutics Inc	FILSPARI	sparsentan	68974-200	POLYETHYLENE GLYCOL	2031-09-05
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for sparsentan

Excipient focus: ANHYDROUS LACTOSE

sparsentan drug variants containing ANHYDROUS LACTOSE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Travere Therapeutics Inc	sparsentan	68974-200
>Company	>Ingredient	>NDC

sparsentan drug variants not containing ANHYDROUS LACTOSE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CELLULOSE, MICROCRYSTALLINE

sparsentan drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Travere Therapeutics Inc	sparsentan	68974-200
>Company	>Ingredient	>NDC

sparsentan drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

sparsentan drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Travere Therapeutics Inc	sparsentan	68974-200
>Company	>Ingredient	>NDC

sparsentan drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYETHYLENE GLYCOL

sparsentan drug variants containing POLYETHYLENE GLYCOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Travere Therapeutics Inc	sparsentan	68974-200
>Company	>Ingredient	>NDC

sparsentan drug variants not containing POLYETHYLENE GLYCOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYVINYL ALCOHOL

sparsentan drug variants containing POLYVINYL ALCOHOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Travere Therapeutics Inc	sparsentan	68974-200
>Company	>Ingredient	>NDC

sparsentan drug variants not containing POLYVINYL ALCOHOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SILICON DIOXIDE

sparsentan drug variants containing SILICON DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Travere Therapeutics Inc	sparsentan	68974-200
>Company	>Ingredient	>NDC

sparsentan drug variants not containing SILICON DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A

sparsentan drug variants containing SODIUM STARCH GLYCOLATE TYPE A

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Travere Therapeutics Inc	sparsentan	68974-200
>Company	>Ingredient	>NDC

sparsentan drug variants not containing SODIUM STARCH GLYCOLATE TYPE A

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TALC

sparsentan drug variants containing TALC

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Travere Therapeutics Inc	sparsentan	68974-200
>Company	>Ingredient	>NDC

sparsentan drug variants not containing TALC

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

sparsentan drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Travere Therapeutics Inc	sparsentan	68974-200
>Company	>Ingredient	>NDC

sparsentan drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.